RELEASE DATE:  June 4, 2003



National Institute on Drug Abuse (NIDA)

The National Institute on Drug Abuse (NIDA) is soliciting proposals 
from qualified organizations having capability to perform quantitative 
analysis of cannabinoids, cocaine and metabolites, opiates, l-alpha-
acetylmethadol, phencyclidine, LSD and other drugs of abuse in 
biological fluids (blood, saliva, plasma, urine) and tissues by means 
of gas chromatography/mass spectrometry (GC/MS).  The analyses must be 
specific and sensitive as required for pharmacokinetic studies 
(generally in the low ng/ml range).  The offeror must possess the 
necessary laboratory space, instrumentation, and experience in assays 
of cannabinoids and other drugs of abuse to carry out these tasks. To 
handle test substances under the controlled Substances Act of 1970, 
offerors must possess a DEA Research Registration for Schedules II to 
V.  NIDA may also require a Schedule I DEA Research Registration.   It 
is estimated that a 5 year incrementally funded cost-reimbursement type 
(completion) contract will be awarded.  RFP No. N01DA-4-7737 will be 
available electronically on or about June 4, 2003.  You can access the 
RFP through Fedbizopps (URL: http://www.fedbizopps.gov or through the 
NIDA website at the following: (URL: 
http://www.eps.gov/servlet/Solicitation/R/HHS/NIH/NIDA/N01DA-4-7737 ).  
Please note that the RFP for this acquisition will be streamlined to 
include only the work statement, Deliverables and Reporting 
Requirements, Special Requirements and Mandatory Qualifications, 
Technical criteria, and other necessary Proposal Preparation 
Instructions.  All information required for the submission of an offer 
will be contained in or accessible through the electronic RFP package.  
Responses to the RFP will be due on or about July 21, 2003.  This 
advertisement does not commit the Government to award.  See Note 26.

Original Point of Contact

Dawn Rabunsky, Contract Specialist, NIDA/NIH, National Institute on 
Drug Abuse, NIH
Contracts Management Branch, OPRM
6001 Executive Blvd., Room 3105, MSC 9543
Bethesda, Maryland  20892-9543
Telephone: (301) 443-6677
Fax:  (301) 443-7595
Email: dr23a@nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

H H S Department of Health
and Human Services

  N I H National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892